Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. WuXi Biologics (Cayman) Inc.
  6. Calendar
    2269   KYG970081173

WUXI BIOLOGICS (CAYMAN) INC.

(2269)
  Report
Delayed Hong Kong Stock Exchange  -  04:08 2022-09-23 am EDT
46.40 HKD   -2.62%
09/20WuXi Biologics Drug Substance and Drug Product Facilities Again Approved by U.S. FDA and EMA
AQ
09/19WuXi Biologics' Drug Substance and Drug Product Facilities Again Approved by U.S. FDA and EMA
AQ
09/19WuXi Biologics Inc. Receives Regulatory Approvals for Drug Substance and Drug Product Facilities from U.S. FDA and EMA
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart WUXI BIOLOGICS (CAYMAN) INC.
Upcoming events on WUXI BIOLOGICS (CAYMAN) INC.
09/25/22 | 09:30pm J.P. Morgan Global Healthcare Shanghai Conference
03/20/23 FY 2022 Earnings Release (Projected)
08/21/23 Interim 2023 Earnings Release (Projected)
03/18/24 FY 2023 Earnings Release (Projected)
08/19/24 Interim 2024 Earnings Release (Projected)
Past events on WUXI BIOLOGICS (CAYMAN) INC.
08/17/22 Interim 2022 Earnings Release
03/22/22 FY 2021 Earnings Call - Slides
03/22/22 FY 2021 Earnings Release
01/12/22 | 09:45am J.P. Morgan Healthcare Conference
11/23/21 Extraordinary Shareholders Meeting
11/18/21 Morgan Stanley Asia Pacific Summit
11/16/21 Jefferies London Healthcare Conference
11/15/21 Goldman Sachs Asia Pacific Healthcare Forum
11/11/21 Nomura China Healthcare Corporate Day
11/09/21 Daiwa Investment Conference
Past dividends on WUXI BIOLOGICS (CAYMAN) INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M CNY
Released
Forecast
Spread
1 619
1 558
3,9%
2 535
2 518
0,66%
3 984
3 870
2,9%
5 612
5 491
2,2%
10 290
9 844
4,5%
 
15 266
 
Operating income
(EBITDA)
M CNY
Released
Forecast
Spread
609
587
3,7%
1 083
899
20%
1 671
1 427
17%
2 464
1 996
23%
4 590
4 150
11%
 
6 338
 
Operating profit
(EBIT)
M CNY
Released
Forecast
Spread
486
424
15%
871
656
33%
1 156
1 038
11%
2 008
1 438
40%
3 327
3 382
-1,6%
 
5 161
 
Pre-Tax Profit
(EBT)
M CNY
Released
Forecast
Spread
304
356
-15%
738
712
3,6%
1 127
1 139
-1,1%
1 966
1 682
17%
3 993
3 586
11%
 
5 583
 
Net income
M CNY
Released
Forecast
Spread
253
250
0,96%
631
606
4,0%
1 010
999
1,1%
1 689
1 548
9,1%
3 388
3 060
11%
 
4 815
 
EPS
CNY
Released
Forecast
Spread
0,07
0,07
6,6%
0,16
0,16
0,47%
0,25
0,24
3,5%
0,40
0,42
-5,2%
0,77
0,74
4,4%
 
1,10
 
Announcement Date03/19/201803/18/201903/26/202003/23/202103/22/2022-
Quarterly results
Fiscal Period : December2020 S12020 S22021 S12021 S22022 S12022 S2
Sales
M CNY
Released
Forecast
Spread
1 944
1 944
0,01%
3 668
3 579
2,5%
4 407
3 722
18%
5 883
5 573
5,6%
7 206
7 139
0,94%
 
8 191
 
Operating income
(EBITDA)
M CNY
Released
Forecast
Spread


 


 


 


 


 
 

 
Operating profit
(EBIT)
M CNY
Released
Forecast
Spread


 


 
1 773
1 298
37%
1 553
1 760
-12%

2 843
 
 
2 348
 
Pre-Tax Profit
(EBT)
M CNY
Released
Forecast
Spread


 
1 261
720
75%


 


 


 
 
3 065
 
Net income
M CNY
Released
Forecast
Spread


 
953
480
98%


 
1 546
1 631
-5,2%


 
 

 
EPS
Released
Forecast
Spread


 


 


 


 


 
 

 
Announcement Date09/21/202003/23/202108/23/202103/22/202208/17/2022-
Previous year Next Year
Upcoming sector events for WUXI BIOLOGICS (CAYMAN) INC.
More events
Past sector events for WUXI BIOLOGICS (CAYMAN) INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise